Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
341 studies found for:    "Abdominal Neoplasms"
Show Display Options
Rank Status Study
1 Unknown  EUS GUIDED Transduodenal Biopsy Using the 19G Flex
Condition: Abdominal Neoplasms
Intervention: Device: Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA)
2 Recruiting Malignant Pediatric Pelvic Tumors: A Retrospective Study
Conditions: Abdominal Neoplasms;   Pelvic Neoplasms
Intervention:
3 Completed Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
Condition: Abdominal Neoplasms
Interventions: Drug: enoxaparin;   Other: Physical prophylaxis
4 Recruiting Evaluation of Pcv-aCO2 in the Fluid Treatment of Abdominal Tumor Patients After Surgery
Conditions: Abdominal Tumor;   Abdominal Infection
Interventions: Other: standardized fluid therapy;   Other: conventional fluid therapy
5 Completed Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
Conditions: Abdominal Neoplasms;   Pelvic Neoplasms
Intervention: Drug: Optison
6 Completed Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy
Conditions: Gynecologic Neoplasms;   Abdominal Neoplasms
Interventions: Other: Augmented ventilation;   Other: Fluid loading
7 Completed TAP Versus Thoracic Epidural in Major Abdominal Resections
Conditions: Malignant Neoplasm of Abdomen;   Surgery
Interventions: Drug: Exparel 1.33% (20ml Volume);   Drug: 0.125% bupivicaine with 2 mcg/ml Fentanyl.
8 Completed Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer
Conditions: Surgery;   Perioperative Care;   Immunization;   Abdominal Neoplasms
Interventions: Behavioral: perioperative fluid management;   Behavioral: perioperative fluid treatment
9 Unknown  Nutritional Supplementation in Patients With no Signs of Malnutrition
Conditions: Primary Neoplasm;   Secondary Neoplasm;   Abdominal Neoplasm
Intervention: Dietary Supplement: Nutritional supplements
10 Completed
Has Results
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
Conditions: Abdominal Neoplasm;   Colonic Neoplasm;   Mesothelioma;   Peritoneal Neoplasm
Interventions: Procedure: Surgery;   Procedure: Continuous hyperthermic peritoneal perfusion (CHPP) with Cisplatin;   Drug: Postoperative dwell with paclitaxel and 5-FU
11 Recruiting Effect of Wound Infiltration by Ketamine Versus Dexmedetomidine Added to Bupivacaine on Surgical Stress
Condition: Abdominal Cancer
Interventions: Drug: Dexmedetomidine;   Drug: Ketamine;   Drug: Bupivacaine
12 Completed Efficacy of Transverses Abdominis -Plane Block With Bupivacaine Versus Bupivacaine With Morphine Postoperatively
Condition: Abdominal Cancer
Intervention: Drug: transversus abdominis-plane block with local anesthetic 20 ml of bupivacaine 0.5% + 10 mg morphine
13 Unknown  Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in Radiotherapy
Conditions: Tumor Motion;   "Continuous Positive Airway Pressure";   Lung Cancer;   Breast Cancer;   Abdominal Tumors
Intervention: Device: Continuous positive airway pressure (CPAP)
14 Completed Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours
Conditions: Cancer of Kidney and Renal Pelvis;   Cancer of Liver
Intervention: Drug: Dexmedetomidine
15 Unknown  Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients
Conditions: Abdominal Tumor;   Intestinal Obstruction;   Cirrhosis;   Intestinal Fistula;   Aneurism
Interventions: Drug: dexmedetomidine;   Drug: propofol
16 Completed Comparison of Hemodynamics Between Dexmedetomidine and Propofol for Sedation in Patients With Abdominal Surgery
Conditions: Disorder; Mental, Sedative;   Pain, Postoperative;   Surgery
Interventions: Drug: Propofol;   Drug: Dexmedetomidine
17 Active, not recruiting Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Fallopian Tube;   Primary Peritoneal Cancer;   Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian
Intervention: Drug: ABT-767
18 Completed Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery
Conditions: Malignant Gastrointestinal Neoplasm;   Malignant Peritoneal Neoplasm
Interventions: Device: Management of Therapy Complications Fitbit Zip (portable pedometer device);   Other: Questionnaire Administration;   Other: Quality-of-Life Assessment
19 Active, not recruiting AZD1775 Plus Chemotherapy in Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Condition: Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
Interventions: Drug: AZD1775 + carboplatin;   Drug: AZD1775 + PLD
20 Recruiting "Re-Stimulated" Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy in Patients With Platinum Resistant High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Condition: Recurrent, Platinum Resistant High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Interventions: Biological: Re-stimulated tumor-infiltrating lymphocytes (TILs);   Biological: Interleukin-2;   Drug: Cyclophosphamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.